Provention Stock Analysis

PRVB -  USA Stock  

USD 8.47  0.02  0.24%

The big decline in price over the last few months for Provention Biomay encourage investors to take a closer look at the company as it is trading at a share price of 8.47 on 455,657 in trading volume. The company directors and management failed to add value to investors and positioning the company supply of money to exploit market volatility in May. However, diversifying your holdings with Provention Bio or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.79. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Provention Bio partners.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Provention Bio stock analysis report makes it easy to digest most publicly released information about Provention Bio and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Provention stock analysis module also helps to analyze the Provention Bio price relationship with some important fundamental indicators such as market cap and management efficiency.

Provention Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The book value of Provention Bio was at this time reported as 1.97. The company recorded a loss per share of 1.88. Provention Bio had not issued any dividends in recent years. Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company was incorporated in 2016 and is headquartered in Red Bank, New Jersey. Provention Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. To find out more about Provention Bio contact Ashleigh Palmer at 908 336 0360 or learn more at http://www.proventionbio.com.

Provention Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Provention Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Provention Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Provention Bio generates negative expected return over the last 90 days
Provention Bio has high historical volatility and very poor performance
Provention Bio has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (98.58 M).
Provention Bio currently holds about 121.82 M in cash with (76.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92.
Roughly 19.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: Glancy Prongay Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Provention Bio, Inc. - Yahoo Finance

Provention Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Provention Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Provention Bio backward and forwards among themselves. Provention Bio's institutional investor refers to the entity that pools money to purchase Provention Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares4.5 M46.8 M
Gilder Gagnon Howe Co LlcCommon Shares3.1 M32.6 M
Perceptive Advisors LlcCommon Shares2.9 M29.9 M
Vanguard Group IncCommon Shares2.8 M29.6 M
State Street CorpCommon Shares1.1 M11.4 M
Two Sigma Advisers LpCommon Shares900.4 K9.4 M
Geode Capital Management LlcCommon Shares865.8 K9.1 M
Group One Trading LpCall Options463.6 K4.9 M
Note, although Provention Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Provention Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 517.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Provention Bio's market, we take the total number of its shares issued and multiply it by Provention Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (58.09) % which means that it has lost $58.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (102.03) %, meaning that it created substantial loss on money invested by shareholders. Provention Bio management efficiency ratios could be used to measure how well provention bio manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Provention Bio holds the coefficient of variation of (1,366), and Risk Adjusted Performance of (0.036699). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Provention Bio, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Provention Bio, which can be compared to its competitors. Please check Provention Bio variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Provention Bio is priced some-what accurately, providing market reflects its current price of 8.47 per share. Given that Provention Bio has jensen alpha of (0.45), we recommend you to check out Provention Bio's recent market performance to make sure the company can sustain itself at a future point.

Provention Bio Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Provention Bio more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Provention Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Provention Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Provention Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Provention Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Provention Bio Predictive Daily Indicators

Provention Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Provention Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Provention Bio Forecast Models

Provention Bio time-series forecasting models is one of many Provention Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Provention Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Provention Bio Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Provention Bio stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Provention shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Provention Bio. By using and applying Provention Stock analysis, traders can create a robust methodology for identifying Provention entry and exit points for their positions.
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The company was incorporated in 2016 and is headquartered in Red Bank, New Jersey. Provention Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Provention Bio to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module
Please check Your Equity Center. Note that the Provention Bio information on this page should be used as a complementary analysis to other Provention Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Provention Bio Stock analysis

When running Provention Bio stock analysis, check to measure Provention Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Provention Bio is operating at the current time. Most of Provention Bio's stock examination focuses on studying past and present price action to predict the probability of Provention Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Provention Bio's price. Additionally, you may evaluate how the addition of Provention Bio to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
The market value of Provention Bio is measured differently than its book value, which is the value of Provention that is recorded on the company's balance sheet. Investors also form their own opinion of Provention Bio stock's value that differs from its market value or its book value, called intrinsic value, which is Provention Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Provention Bio's market value can be influenced by many factors that don't directly affect Provention Bio underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Provention Bio's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Provention Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Provention Bio's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.